Scholarly publications and presentations by Rochester Regional Health authors.
Submissions from 2026
10-1-2026 General dentists' approach to dental management of patients taking anticoagulants: a national survey-based assessment: pre- and post-procedure practice, Sharon Elad, Rebekah Boy, Michael C. Leo, et al.
10-1-2026 Impact of environmental heavy metal exposure on cardiovascular disease mortality, Karthik Gonuguntla, Waleed Alruwaili, Harshith Thyagaturu, et al.
10-1-2026 In-hospital outcomes of sepsis hospitalizations among patients with cardiac amyloidosis: A 2022 National inpatient sample analysis, Ahmed M. Saad, Fahad Eid, Rochester Regional Health, Mohammed Abozenah, et al.
9-15-2026 Demographics and clinical implications of a global bibliographic profile for the hypertrophic cardiomyopathy literature over 66 years (1960-2025), Ahmed Sayed, Rochester Regional Health, Ethan J. Rowin, Martin S. Maron, et al.
9-1-2026 Cerebral embolic protection devices for transcatheter aortic valve replacement: A meta-analysis and trial sequential analysis, Hossam Elbenawi, Ibrahim Hassan, Mahmoud Shaaban Abdelgalil, et al.
9-1-2026 Comparing the diagnostic performance of 19-gauge and 22-gauge needles in endoscopic ultrasound-guided liver biopsy: a systematic review and meta-analysis, Muhammad Ali Butt, Rahul Karna, Sheza Malik, Rochester Regional Health, et al.
9-1-2026 Hydrocortisone Use for Septic Shock in Patients With CKD, Parth Dhamelia, Hashane Abeyagunawardene, Rajshekhar A. Kore, et al.
9-1-2026 Incidence and Cost of Otitis Media in High-income and Low- and Middle-income Countries, Andrew Cox, Rochester Regional Health; Ravinder Kaur, Rochester Regional Health; and Michael E. Pichichero, Rochester Regional Health
9-1-2026 Managing Legacy Opioid Patients, Patients with Comorbid Substance Use, and a Role for Buprenorphine for Pain, Richard Scott Dent, Rochester Regional Health
9-1-2026 Prognosis of Patients with Lung Cancer Admitted to the Intensive Care Unit: A Systematic Review and Meta-Analysis, Ahmed Elkhapery, Rochester Regional Health, Hazem Taifour, Rochester Regional Health, Chengu Niu, Rochester Regional Health, et al.
8-24-2026 Redo-TAVR (TAV-in-TAV) Best Practices Part 2: Tall-in-Short and Tall-in-Tall: A Heart and Valve Collaboratory Document, Vinayak N. Bapat, Syed Zaid, Miho Fukui, et al.
8-10-2026 Redo-TAVR (TAV-in-TAV) Best Practices Part 1: Short-in-Short and Short-in-Tall: A Heart and Valve Collaboratory Document, Andrei Pop, Syed Zaid, Miho Fukui, et al.
8-5-2026 Loeffler Endocarditis: Multimodality Imaging of a Common Cardiac Phenotype in Distinct Hypereosinophilic Syndromes, Tooba Salar, Rochester Regional Health, Scott Feitell, Rochester Regional Health, Vishal Parikh, Rochester Regional Health, et al.
8-1-2026 ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 ABCL-1276: Reversal of Declining Gastrointestinal Hemorrhage-Associated Mortality in Hematologic Malignancies in the United States: A CDC WONDER Analysis, Gaurav Sharma; Shashank Trivedi, Rochester Regional Health; and Moksha Prasoona Avvaru
8-1-2026 ABCL-669: Reversible Locked-in–Like Syndrome From Ifosfamide Encephalopathy in Relapsed T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Mutasim Idriss, Rochester Regional Health, ELrazi Ali, Mohamed Hegazi, et al.
8-1-2026 ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.
8-1-2026 ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.
8-1-2026 Acute Interstitial Nephritis after Single Dose of Ketorolac, Ishan Jani, Rochester Regional Health; Arjun Sekar, Rochester Regional Health; and Sergey Brodsky
8-1-2026 Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial, Kashish Goel, Brian R. Lindman, Allan Schwartz, et al.
8-1-2026 ALL-1229: Clinical Impact of Tumor Lysis Syndrome in Acute Leukemia: A Comparative Analysis of Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, Jawad Ahmed, Farheen Malik, Osama Mohiuddin, et al.
8-1-2026 AML-1359: Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023, Yojan Chandra Reddy Vennapusa, Deep Sanjaykumar Sangani, Rutvij Bharatsinh Solanki, et al.
8-1-2026 AML-1700: Leukemia Mortality Among Patients With Substance Use Disorder in the United States, 1999–2020: A Population-Based Analysis of Trends and Disparities, Parth Desai, Rutvij Bharatsinh Solanki, Deep Sanjaykumar Sangani, et al.
8-1-2026 AML-1733: Trends in Acute Myeloid Leukemia Mortality Among Female Patients in the United States, 1999–2020: A Population-Based Analysis of Average Annual Percent Change, Krishna Sajeev, Rochester Regional Health, Sai Varun Gadde, FNU Bhuvan, et al.
8-1-2026 AML-1737: Pneumonia as a Contributing Cause of Death in Acute Myeloid Leukemia Patients: A 22-Year Population-Based Analysis of Trends in the United States, 1999–2020, Rutvij Solanki, Parth Desai, Yojan Chandra Reddy Vennapusa, et al.
8-1-2026 AML-1739: Racial Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018–2024: A Nationwide Trend Analysis Across 15 Racial Groups, Sai Varun Gadde, Krishna Sajeev, Rochester Regional Health, FNU Bhuvan, et al.
8-1-2026 CLL-046: Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Chronic Lymphocytic Leukemia Patients (2017–2021), Toluwani Balogun, Rochester Regional Health, Purva Shah, Rochester Regional Health, Vasudha Garg, Rochester Regional Health, et al.
8-1-2026 CLL-1558: Outcomes of Venetoclax Retreatment After Prior Frontline Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis, Mutasim Idriss, Rochester Regional Health, Summiya Nasim, Muhammad Junaid, et al.
8-1-2026 Disappearing glomeruli: loss of linear IgG in anti-GBM nephritis, Dalia Ibrahim, Ahmed Abdelfattah, Marvin Grieff, Rochester Regional Health, et al.
8-1-2026 Disparities in Palliative Care Utilization in Metastatic Triple-negative Breast Cancer: A National Cancer Database Study, Cher Ying Foo, Rochester Regional Health, Ojasav Sehrawat, Rochester Regional Health, Akshjot Puri, et al.
8-1-2026 MCL-668: Infectious Complications in Patients With Mantle Cell Lymphoma Treated With CAR-T Therapy: A Real-World TriNetX Analysis, Anushree Venkatesh Murthy, Rochester Regional Health, Adithya Nagendran, Rochester Regional Health, Logesh Durairaj, Rochester Regional Health, et al.
8-1-2026 MM-1033: Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 MM-1033: Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 MM-1400: Disseminated Intravascular Coagulation in Multiple Myeloma: A Nationwide Analysis of Mortality, Organ Failure, and Healthcare Utilization, Jawad Ahmed, Dua Azim, Rochester Regional Health, Abdul Ghani Iqbal, et al.
8-1-2026 MM-1692: Global, Regional, and National Macroeconomic Burden of Multiple Myeloma: An Age-Stratified Value-of-Lost-Welfare Analysis of 184 Countries, 2023, Hardik Dineshbhai Desai, Digantkumar Patel, Aditya Ahuja, et al.
8-1-2026 MM-1738: Three Decades of Rising Disparity: Global Burden, Temporal Trends, and Sociodemographic Inequities of Multiple Myeloma in Women, 1990–2023, Deep Sangani, FNU Bhuvan, Sai Varun Gadde, et al.
8-1-2026 MM-1740: Narrowing Burden, Widening Gaps: A 26-Year Population-Based Analysis of Renal Failure as Contributing Cause of Death in Multiple Myeloma, 1999–2024, FNU Bhuvan, Sai Varun Gadde, Krishna Sajeev, Rochester Regional Health, et al.
8-1-2026 Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial, Gregg W. Stone, JoAnn Lindenfeld, Michael R. Zile, et al.
8-1-2026 Optical coherence tomography versus angiography guided percutaneous coronary intervention: a systematic review and meta-analysis, Zeeshan Sattar, Mohammad Hamza, Junaid Mir, et al.
8-1-2026 Plasma metabolomics in infancy reveals early signatures of a stringently-defined otitis-prone phenotype, Nicole Prince, Jing Chen, Ravinder Kaur, Rochester Regional Health, et al.
8-1-2026 POSTER: ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 POSTER: ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.
8-1-2026 POSTER: ABCL-1276: Reversal of Declining Gastrointestinal Hemorrhage-Associated Mortality in Hematologic Malignancies in the United States: ACDCWONDER Analysis, Gaurav Sharma; Shashank Trivedi, Rochester Regional Health; and Moksha Prasoona Avvaru
8-1-2026 POSTER: ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.
8-1-2026 POSTER: ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.
8-1-2026 POSTER: ALL-1229: Clinical Impact of Tumor Lysis Syndrome in Acute Leukemia: A Comparative Analysis of Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, Jawad Ahmed, Farheen Malik, Osama Mohiuddin, et al.
8-1-2026 POSTER: AML-1359: Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023, Yojan Chandra Reddy Vennapusa, Deep Sanjaykumar Sangani, Rutvij Bharatsinh Solanki, et al.
8-1-2026 POSTER: AML-1700: Leukemia Mortality Among Patients With Substance Use Disorder in the United States, 1999–2020: A Population-Based Analysis of Trends and Disparities, Parth Desai, Rutvij Bharatsinh Solanki, Deep Sanjaykumar Sangani, et al.
8-1-2026 POSTER: AML-1733: Trends in Acute Myeloid Leukemia Mortality Among Female Patients in the United States, 1999–2020: A Population-Based Analysis of Average Annual Percent Change, Krishna Sajeev, Rochester Regional Health, Sai Varun Gadde, FNU Bhuvan, et al.